|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
AU773834B2
(en)
*
|
1998-12-03 |
2004-06-10 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
CN1347450A
(zh)
*
|
1999-04-09 |
2002-05-01 |
阿文蒂斯药物股份有限公司 |
用于保存感染性重组腺病毒的组合物
|
|
FR2791999B1
(fr)
*
|
1999-04-09 |
2001-09-07 |
Aventis Pharma Sa |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
EP2420247A1
(en)
|
2000-03-07 |
2012-02-22 |
Merck Sharp & Dohme Corp. |
Adenovirus formulations
|
|
US7456009B2
(en)
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
EP1284287A4
(en)
*
|
2000-05-10 |
2004-10-13 |
Mitsubishi Pharma Corp |
METHOD FOR PRODUCING A VIRUS VECTOR
|
|
CA2469623C
(en)
|
2001-12-12 |
2012-05-29 |
F H Faulding & Co Limited |
Composition for the preservation of viruses
|
|
BR0306925A
(pt)
*
|
2002-01-18 |
2004-11-09 |
Schering Ag |
Formulações estabilizadas de adenovìrus
|
|
KR100507794B1
(ko)
*
|
2003-02-11 |
2005-08-17 |
한미약품 주식회사 |
고농도 레트로 바이러스 현탁액 제조 방법
|
|
WO2005052116A2
(en)
*
|
2003-11-19 |
2005-06-09 |
Merck & Co., Inc. |
Preservative-containing virus formulations
|
|
US20070207461A1
(en)
*
|
2004-02-23 |
2007-09-06 |
Crucell Holland B.V. |
Virus Purification Methods
|
|
GB0502661D0
(en)
*
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
CA2602944C
(en)
*
|
2005-04-11 |
2015-08-11 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
CN1961961B
(zh)
*
|
2005-11-11 |
2010-05-26 |
深圳市源兴生物医药科技有限公司 |
一种药物制剂及其制备方法
|
|
WO2010060719A1
(en)
|
2008-11-03 |
2010-06-03 |
Crucell Holland B.V. |
Method for the production of adenoviral vectors
|
|
PL2536829T3
(pl)
|
2010-02-15 |
2016-09-30 |
|
Sposób wytwarzania wektorów adenowirusowych Ad26
|
|
AP3390A
(en)
|
2010-09-20 |
2015-08-31 |
Crucell Holland Bv |
Therapeutic vaccination against active tuberculosis
|
|
US9168292B2
(en)
|
2010-09-27 |
2015-10-27 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
|
MX350932B
(es)
|
2010-12-02 |
2017-09-26 |
Oncolytics Biotech Inc |
Formulaciones virales liquidas.
|
|
EA201390812A1
(ru)
|
2010-12-02 |
2013-11-29 |
Онколитикс Байотек Инк. |
Лиофилизированные вирусные составы
|
|
PL2825640T3
(pl)
|
2012-03-12 |
2016-10-31 |
|
Partie rekombinowanych adenowirusów o zmienionych końcach
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
SG11201405804YA
(en)
|
2012-03-22 |
2014-10-30 |
Crucell Holland Bv |
Vaccine against rsv
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
CN104640564B
(zh)
|
2012-07-10 |
2020-08-04 |
特兰斯吉恩股份有限公司 |
分枝杆菌抗原疫苗
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
TR201902513T4
(tr)
|
2013-04-25 |
2019-03-21 |
Janssen Vaccines & Prevention Bv |
Stabilize edilmiş çözünebilir prefüzyon RSV F polipeptitleri.
|
|
PE20160045A1
(es)
|
2013-06-17 |
2016-02-18 |
Crucell Holland Bv |
Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados
|
|
KR20160130216A
(ko)
|
2014-01-09 |
2016-11-10 |
트랜스진 에스아이 |
헤테로올리고머 미코박테리아 항원의 융합물
|
|
US9721484B2
(en)
|
2014-06-23 |
2017-08-01 |
Humanetics Innovative Solutions, Inc. |
Shoulder kit assembly for crash test dummy
|
|
PT3169341T
(pt)
|
2014-07-16 |
2019-09-09 |
Transgene Sa |
Vírus oncolítico para a expressão de moduladores de pontos de controlo imunitário
|
|
US10008130B2
(en)
|
2014-09-17 |
2018-06-26 |
Humanetics Innovative Solutions, Inc. |
Omni-directional shoulder assembly for crash test dummy
|
|
US20180028626A1
(en)
|
2015-02-13 |
2018-02-01 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
CA2981841A1
(en)
|
2015-04-14 |
2016-10-20 |
Janssen Vaccines & Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
AU2016289492B2
(en)
|
2015-07-07 |
2022-08-11 |
Janssen Vaccines & Prevention B.V. |
Vaccine against RSV
|
|
BR112017028449A2
(pt)
|
2015-07-07 |
2018-09-04 |
Janssen Vaccines & Prevention Bv |
polipeptídeos rsv f pré-fusão solúveis estabilizados
|
|
ES2858315T3
(es)
|
2016-04-05 |
2021-09-30 |
Janssen Vaccines & Prevention Bv |
Proteína F de prefusión de VRS soluble estabilizada para uso en la profilaxis de la infección por VRS
|
|
EA201892250A1
(ru)
|
2016-04-05 |
2019-03-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
|
RU2758238C2
(ru)
|
2016-05-12 |
2021-10-26 |
Янссен Вэксинс Энд Превеншн Б.В. |
Эффективный и сбалансированный двунаправленный промотор
|
|
IL264119B2
(en)
|
2016-05-30 |
2023-04-01 |
Janssen Vaccines Prevention B V |
f proteins of rsv are stabilized before fusion
|
|
CN109312362B
(zh)
|
2016-06-20 |
2022-06-28 |
扬森疫苗与预防公司 |
有效和平衡的双向启动子
|
|
US10744196B2
(en)
|
2016-07-14 |
2020-08-18 |
Janssen Vaccines & Prevention B.V. |
HPV vaccines
|
|
WO2018049261A1
(en)
|
2016-09-09 |
2018-03-15 |
Icellhealth Consulting Llc |
Oncolytic virus expressing immune checkpoint modulators
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
US20190330655A1
(en)
|
2016-12-28 |
2019-10-31 |
Transgene Sa |
Oncolytic viruses and therapeutic molecules
|
|
KR102111244B1
(ko)
|
2017-02-09 |
2020-05-15 |
얀센 백신스 앤드 프리벤션 비.브이. |
이종 유전자의 발현을 위한 강력한 짧은 프로모터
|
|
WO2018210871A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
EP3624844A1
(en)
|
2017-05-17 |
2020-03-25 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
US11229695B2
(en)
|
2017-09-15 |
2022-01-25 |
Janssen Vaccines & Prevention B.V. |
Method for the safe induction of immunity against RSV
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
JP7557738B2
(ja)
|
2018-10-30 |
2024-09-30 |
国立大学法人 東京大学 |
がん治療のための腫瘍溶解性ウイルス
|
|
EP3880243A1
(en)
|
2018-11-13 |
2021-09-22 |
Janssen Vaccines & Prevention B.V. |
Stabilized pre-fusion rsv f proteins
|
|
TW202204380A
(zh)
|
2020-01-31 |
2022-02-01 |
美商詹森藥物公司 |
用於預防及治療冠狀病毒感染之組合物及方法－sars-cov-2疫苗
|
|
WO2021186246A1
(en)
|
2020-03-19 |
2021-09-23 |
Trizell Ltd. |
Temperature-responsive virus storage system
|
|
US20230256057A1
(en)
|
2020-07-13 |
2023-08-17 |
Transgene |
Treatment of immune depression
|
|
WO2022161502A1
(zh)
|
2021-02-01 |
2022-08-04 |
羿尊生物医药（浙江）有限公司 |
一种靶向蛋白降解系统及其应用
|
|
MX2023009738A
(es)
|
2021-02-19 |
2023-08-30 |
Janssen Vaccines & Prevention Bv |
Antigenos de rsv fb prefusion estabilizados.
|
|
WO2023020939A1
(en)
|
2021-08-17 |
2023-02-23 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
WO2023111725A1
(en)
|
2021-12-14 |
2023-06-22 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
CA3260559A1
(en)
|
2022-07-01 |
2024-01-04 |
Transgene |
Fusion protein comprising a surfactant D protein and a component of TNFSF
|
|
CA3261778A1
(en)
|
2022-08-18 |
2024-02-22 |
Transgene |
CHIMERIC POXVIRUSES
|